Insulet Corporation

NASDAQ: PODD
$268.00
+$23.02 (+9.4%)
Closing Price on November 8, 2024

PODD Stock Chart and Intraday Price

PODD Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Address 9 OAK PARK DRIVE, BEDFORD, MA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 11,834.92M USD
Shares Outstanding 69,926,000
Insulet Corporation specializes in innovative insulin delivery systems for those with insulin-dependent diabetes. Its flagship Omnipod platform offers a range of products, including the Omnipod 5, which integrates with continuous glucose monitors for automated insulin delivery, and the Omnipod DASH, a smartphone-like device managing insulin delivery with ease. Additionally, the Omnipod GO provides a simple, wearable insulin delivery option. With a focus on accessibility, Insulet sells its products globally through distributors, pharmacies, and direct sales, aiming to improve the lives of people with diabetes around the world. Founded in 2000, the company is based in Acton, Massachusetts.

PODD Articles

Tuesday's top analyst upgrades and downgrades included AppLovin, Block, ConocoPhillips, Datadog, FedEx, Nvidia, Okta, PayPal, Rivian Automotive, Toast and Zscaler.
Monday's top analyst upgrades and downgrades included Altice USA, Arista Networks, Block, Cardinal Health, ConocoPhillips, Datadog, GoodRx, Monster Beverage, PepsiCo, Spirit AeroSystems, Twilio and...
Tuesday's top analyst upgrades and downgrades included Airbnb, American Express, Fastly, JPMorgan Chase, Mattel, Nike, Realty Income, Redfin, Southwestern Energy and Zillow.
Friday's top analyst upgrades and downgrades included Agnico-Eagle Mines, Biogen, Exelon, Meta Platforms, New York Times, PulteGroup, Snap and Vertex Pharmaceutical.
Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Beyond Meat, Colgate-Palmolive, Edwards Lifesciences, Electronic Arts, Exxon Mobil, Meta Platforms, PayPal and...
Thursday's top analyst upgrades and downgrades included Carnival, Dow, Goldman Sachs, Micron Technology, Netflix, Oracle, Snap, Spotify and Twitter.
Friday's top analyst upgrades and downgrades included Bill.com, CenterPoint Energy, CommScope, Herbalife, Hyatt Hotels, Motorola Solutions, Murphy Oil, Trade Desk and Vonage.
Friday's top analyst upgrades and downgrades included Arch Coal, AT&T, Delphi Technologies, Domino's Pizza, Dunkin Brands, Expedia, Illumina, Kinder Morgan, Oceaneering International, Splunk and...
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk...
Friday's top analyst upgrades, downgrades and initiations included Ambarella, Apple, Comcast, Costco, CSX, Domino's, Dish Network, Etsy, HP, 3M, Nike, PepsiCo and Snap.
Insulet shares surged after it reported earnings. The company's Omnipod insulin management system saw stellar growth in sales.
24/7 Wall St. has included a montage of companies that are seeing multiple upgrades and downgrades on the analyst front as a result of news or earnings.
The top analyst upgrades, downgrades and other research calls from Friday include Activision, Aetna, Apple, Blue Apron, Pandora, Starbucks, Twitter and YogaWorks.
Tuesday’s top analyst upgrades, downgrades and initiations include Apple, CVS Health, Priceline, Teva Pharmaceutical and Workday.
Two recent Wedbush research reports focus is on health care companies that not only have data that could prove to be huge, but that have both been absolutely hammered over the past year.